Updated:
Mount Sinai Ventures
Mount Sinai Ventures was formed in 1967 as the investment management arm of the Mount Sinai Health System, a nonprofit academic medical network headquartered...
Mount Sinai Ventures
Mount Sinai Ventures was formed in 1967 as the investment management arm of the Mount Sinai Health System, a nonprofit academic medical network headquartered in New York City. The entity coordinates fundraising, oversees the pooled investment portfolio, and deploys capital for the system's affiliated entities, functioning less as a passive allocator and more as an active principal across venture, buyout, and distressed strategies. The group pursues a multi-asset mandate spanning early-stage venture, growth equity, buyout, and distressed debt, with a portfolio that includes direct co-investments, joint ventures, and real estate development. Confirmed operating partnerships include a joint venture with U.S. Anesthesia Partners for Greater New York Anesthesia Services, a development deal with Slate Property Group and Evenhar Development on the 1578 Lexington Avenue project in East Harlem, and co-ownership of Peak Point Partners alongside Merritt Healthcare. Geographic deployment concentrates in the New York metro region, with property interests such as the Midtown West Surgery Center and the Far Rockaway Clinic complementing venture exposure to enterprise software, digital health, and AI/ML companies. Managing Director Brent Stackhouse — also a Senior Partner at Spex Capital and a Board Member of Teach for Italy — anchors the investment team. In addition to his operating role, Stackhouse founded Strategic Ventures Group, a consortium of over 60 hospital corporate venture investors that doubles as a proprietary sourcing network. The firm maintains professional ties to Junto Collaborative and the Georgetown Angel Investor Network, further extending deal access. A notable structural move: Stackhouse established the Strategic Ventures Group to formalize peer hospital co-investment, embedding Mount Sinai Ventures within a deal-sharing infrastructure rare among single-system endowments. Mount Sinai Ventures operates with a governance structure deeply intertwined with the health system's operations and philanthropy. Unlike a standalone family office or independent venture fund, the entity functions as an internal portfolio manager for the hospital's aggregated capital, giving it permanent capital flexibility to hold distressed positions and real estate assets across cycles. The organizational design — a nonprofit investment office embedded in a clinical enterprise — creates a long-duration mandate that external limited partners cannot replicate.
General information
Firm type
Venture Capital
Year founded
1967
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Brent Stackhouse
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Mount Sinai Ventures?
Brent Stackhouse serves as Managing Director and is the named lead for Mount Sinai Ventures. He also holds a Senior Partner role at Spex Capital and sits on the board of Teach for Italy. Stackhouse founded Strategic Ventures Group, a consortium of 60-plus hospital corporate venture investors, which suggests centralized decision-making with external advisory input rather than a broad internal investment committee model.
How does Mount Sinai Ventures source proprietary deal flow?
The firm sources through the Strategic Ventures Group — a network of over 60 hospital corporate venture investors founded by Stackhouse — alongside professional relationships with Junto Collaborative and the Georgetown Angel Investor Network. This hospital-consortium model gives Mount Sinai Ventures early visibility on health-tech and healthcare-services companies co-sponsored by peer systems, differentiating it from funds that rely primarily on traditional GP intermediation.
Is Mount Sinai Ventures structured as a single family office or does it operate more like a venture firm?
It operates as the internal investment vehicle for the Mount Sinai Health System endowment — a nonprofit asset owner — not a family office or standalone venture firm. However, its behavior more closely resembles a corporate VC and distressed-debt platform: it makes direct co-investments, forms joint ventures with external operators such as U.S. Anesthesia Partners and Slate Property Group, and engages in buyout transactions.
Does Mount Sinai Ventures participate in fund commitments or only direct deals?
The firm's known activity emphasizes direct co-investments, joint ventures, and real estate development partnerships — including the 1578 Lexington Avenue project and the Peak Point Partners joint venture with Merritt Healthcare. While the pooled investment portfolio may include fund commitments, publicly surfaced activity suggests a strong tilt toward direct engagement rather than serving as a passive LP.
What is Mount Sinai Ventures' known posture on co-investments alongside external GPs?
It actively co-invests with external operators and real estate developers, demonstrated by the Slate Property Group partnership and the U.S. Anesthesia Partners joint venture. The Strategic Ventures Group consortium further embeds co-investment as a structural practice, enabling the firm to participate in venture rounds alongside peer hospital CVCs and external sponsors.
Which sectors does Mount Sinai Ventures explicitly avoid?
No public exclusion list confirms sectors Mount Sinai Ventures avoids. Given its health-system affiliation, the portfolio is heavily concentrated in healthcare services, digital health, enterprise software, AI/ML, and real estate; investment in sectors with reputational risk for a nonprofit hospital — such as tobacco, firearms, or fossil fuels — would be inconsistent with its operating context but remains unconfirmed as formal policy.
Does Mount Sinai Ventures maintain philanthropic structures, and how are they separated?
Mount Sinai Health System Philanthropy serves as the system's fundraising arm, distinct from Mount Sinai Ventures' investment function. The Ventures group manages the pooled investment portfolio and direct transactions, while the Philanthropy entity handles donor relations and grants. No evidence suggests commingling of grant-making and investment-return mandates.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: